Obstructive sleep apnea and cardiovascular disease: Implications for clinical practice
Silke Krieger, MD
Department of General Internal Medicine, Cleveland Clinic
Sean M. Caples, DO
Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
Address: Silke Krieger, MD, Department of General Internal Medicine, S70, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: email@example.com
ABSTRACTObstructive sleep apnea is common, underdiagnosed, undertreated, and highly associated with cardiovascular risk. It is characterized by daytime sleepiness and disrupted sleep and is confirmed by overnight sleep studies (polysomnography). Treatment with continuous positive airway pressure (CPAP) improves sleep and daytime sleepiness, but its effects on cardiovascular risk while promising, are still unclear.